In sum, our results are consistent with previous demonstrations in vitro and in cell culture that non metastatic mammary tumors express IMP1 and that invasive breast cancer metastatic cells have lower IMP1 levels [28]. The gene discussed is IGF2BP1; the disease is breast cancer.